Llagas, Rizelda .
HRN: 21-89-81 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2022
AMPICILLIN 1GM (VIAL)
09/17/2022
09/23/2022
IV
2gm
Q6
PROM
Waiting Final Action
09/21/2022
CEFUROXIME 500MG (TAB)
09/21/2022
09/27/2022
PO
500MG
BID
S/P LTCS
Waiting Final Action